参考文献/References:
［1］ Tinkle CL, Haas- Kogan D. Hepatocellular carcinoma: natural history, current management, and emerging tools［J］. Biologics, 2012, 6: 207- 219.
［2］ Czaja AJ. Current management strategies for hepatocellular carcinoma［J］. Minerva Gastroenterol Dietol, 2013, 59: 143- 159.
［3］ 赵 平， 孔灵芝． 中国肿瘤死亡报告——全国第三次死因回顾抽样调查［M］． 北京： 人民卫生出版社， 2010： 37．
［4］ Luk JM, Liu AM. Proteomics of hepatocellular carcinoma in Chinese patients［J］. OMICS, 2011, 15: 261- 266.
［5］ 张 宁， 王 鲁， 汤钊猷． 肝癌行射频消融术后残癌侵袭转移潜能及机体免疫功能变化的相关研究［J］． 医学研究杂志， 2013， 42： 152- 154．
［6］ Yang Z, Miao R, Li G, et al. Identification of recurrence related microRNAs in hepatocellular carcinoma after surgical resection［J］. Int J Mol Sci, 2013, 14: 1105- 1118.
［7］ 邵泽锋， 何仕诚， 邓 钢， 等． 肝动脉化疗栓塞联合介入技术治疗经导管肝动脉化疗栓塞术术后残留及复发肝癌的疗效观察［J］． 中华临床医师杂志?电子版， 2012， 6： 202- 203．
［8］ Kroeze SG, Van Melick HH, Nijkamp MW, et al. Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model［J］. BJU Int, 2012, 110: E281- E286.
［9］ 韩 峰， 邹如海， 裴小青， 等． 超声造影定量分析鉴别富血供转移性肝癌与肝细胞肝癌［J］． 中国医学影像技术， 2011， 27： 2079- 2082．
［10］ 王坤坤， 张 峰， 郑雅茹， 等． 超声造影量化分析在原发性肝细胞癌介入治疗后残存血供评价中的应用研究［J］． 哈尔滨医科大学学报， 2012， 46： 379- 381．
［11］ Mandai M, Koda M, Matono T, et al. Assessment of hepatocellular carcinoma by contrast- enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT［J］. Br J Radiol, 2011, 84: 499- 507.
［12］ 冯 峰， 施裕新， 夏淦林． TACE术后残留肝癌的影像学研究进展［J］． 国际医学放射学杂志， 2009， 32： 250- 254．
［13］ 黄渊全， 贾中芝， 冯耀良， 等． CT灌注成像在肝癌TACE术后疗效评价中的应用价值［J］． 介入放射学杂志， 2009， 18： 437- 441．
［14］ 彭辽河， 胡晓燕， 李 杰， 等． 18F- FDG PET/CT显像在肝细胞癌TACE术后残留或复发病灶检出中的应用价值［J］． 介入放射学杂志， 2012， 21： 636- 640．
［15］ Ichikawa T, Kumazaki T. Clinical usefulness of computed tomography arteriography and computed tomography during arterial portography for the diagnosis of early and early advanced hepatocellular carcinoma［J］. J Nippon Med Sch, 2000, 67: 105- 109.
［16］ 魏 玮， 郑 敏， 市川太郎， 等． CTAP、 CTA联合应用诊断肝小肿瘤的价值［J］． 中国医学影像学杂志， 2001， 9： 342- 344．
［17］ Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions［J］. Semin Liver Dis, 1999, 19: 297- 309.
［18］ Soyer P, Bluemke DA, Fishman EK. CT during arterial portography for the preoperative evaluation of hepatic tumors: how, when， and why?［J］. AJR Am J Roentgenol, 1994, 163: 1325- 1331.
［19］ Nishie A, Yoshimitsu K, Asayama Y, et al. Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma［J］. AJR Am J Roentgenol, 2008, 190: 81- 87.
［20］ Chezmar JL, Bernardino ME, Kaufman SH, et al. Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress［J］. Radiology, 1993, 189: 407- 410.
［21］ Kanematsu M, Hoshi H, Imaeda T, et al. Detection and characterization of hepatic tumors: value of combined helical CT hepatic arteriography and CT during arterial portography［J］. AJR Am J Roentgenol, 1997, 168: 1193- 1198.
［22］ Yan FH, Zhou KR, Cheng JM, et al. Role and limitation of FMPSPGR dynamic contrast scanning in the follow- up of patients with hepatocellular carcinoma treated by TACE［J］. World J Gastroenterol, 2002, 8: 658- 662.
［23］ 朱光宇， 滕皋军， 郭金和， 等． 正电子发射计算机体层成像CT在监测甲胎蛋白阳性肝癌介入治疗后残留病灶和肝外转移病灶中的作用［J］． 中华放射学杂志， 2010， 44： 726- 730．
［24］ Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusion- weighted imaging in estimating tumor necrosis after chemoembo- lization of hepatocellular carcinoma［J］. AJR Am J Roentgenol, 2003, 181: 708- 710.
［25］ Mahon MM, Williams AD, Soutter WP, et al. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration［J］. NMR Biomed, 2004, 17: 1- 9.
［26］ Kudo M. Diagnostic imaging of hepatocellular carcinoma: recent progress［J］. Oncology, 2011, 81: 73- 85.
［27］ Matthies A, Hickeson M, Cuchiara A, et al. Dual time point 18F- FDG PET for the evaluation of pulmonary nodules［J］. J Nucl Med, 2002, 43: 871- 875.
［28］ Ahn SG, Kim SH, Jeon TJ, et al. The role of preoperative 18Ffluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas［J］. J Gastrointest Surg, 2011, 15: 2044- 2052.
［29］ 陈志丰， 梁 宏， 张祥松， 等． 肝癌治疗后甲胎蛋白增高患者的18F- FDG PET/CT与增强CT对照研究［J］． 南方医科大学学报， 2012， 32： 1615- 1619．
［30］ Lin CY, Chert JH, Liang JA, et al. 18F- FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta- analysis［J］. Eur J Radiol, 2012, 81: 2417- 2422.
［31］ 陈耀庭， 许林锋， 孙宏亮． 介入治疗后CT表现不典型的肝癌残留和复发病灶的早期诊断［J］． 中国医学影像技术， 2012， 28： 948- 952．
［32］ Cheng MF, Wu YW, Tzen KY, et al. Whole- body 18F- FDG PET for hepatocellular carcinoma patients after interventional treatment［J］. Neoplasma, 2007, 54: 342- 347.
［33］ 商健彪， 刘方颖， 李彦豪， 等． 18F- FDG PET、CT和血管造影在原发性肝癌TACE后随访的对比研究［J］． 中国临床医学影像杂志， 2004， 15： 509- 512．
［34］ Lu X, Zhao H, Yang H, et al. A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy［J］. J Surg Oncol, 2009, 100: 488- 493.
［35］ 王红阳． 肝癌诊断与预后判断的分子标志物［J］． 中华肝脏病杂志， 2011， 19： 241- 243．
［36］ Shi YL. Early Diagnosis value of primary hepatic carcinoma combined detection serum AFP- L3, GP73［J］. Beihua Univ（Nat Sci）, 2013, 14: 569- 571.
［37］ Miura N, Osaki Y, Nagashima M, et al. A novel biomarker TERTmRNA is applicable for early detection of hepatoma［J］. BMC Gastroenterol, 2010, 10: 46.
［38］ Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer［J］. Cell Stem Cell, 2007, 1: 313- 323.
［39］ Huang C, Wang Y, Liu S, et al. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvas- cular invasion in hepatocellular carcinoma［J］. J Proteome Res, 2013, 12: 1838- 1846.
［40］ 杨正汉， 周 诚， 杨大为． 肝细胞癌局部微创治疗后的CT、MRI评价［J］． 中华放射学杂志， 2010， 44： 1239- 1243．
相似文献/References:
[1]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良ＲＥＣＩＳＴ标准更可靠[J].介入放射学杂志,2012,(03):177.
. Ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ ｃｒｉｔｅｒｉｏｎ ｏｆ ｉｎｏｐｅｒａｂｌｅ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｍｏｄｉｆｉｅｄ ＲＥＣＩＳＴ ａｓ ａ ｍｏｒｅ ｒｅｌｉａｂｌｅ ｓｔａｎｄａｒｄ[J].journal interventional radiology,2012,(11):177.
[2]梁茂全,苏洪英. 肝癌化疗栓塞前后甲胎蛋白变化模式的临床意义[J].介入放射学杂志,2012,(04):333.
.Ｔｈｅ ｔｒａｎｓｆｏｒｍａｔｉｏｎ ｐａｔｔｅｒｎ ｏｆ ｓｅｒｕｍ аｆｅｔｏｐｒｏｔｅｉｎ ａｆｔｅｒ ｔｒａｎｓｃａｔｈｅｔｅｒ ａｒｔｅｒｉａｌ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａ： ｉｔｓ ｃｌｉｎｉｃａｌ ｓｉｇｎｉｆｉｃａｎｃｅ [J].journal interventional radiology,2012,(11):333.
[3]孙 磊,施海彬,刘 圣,等.肝细胞癌肝动脉门静脉分流形成的相关因素分析[J].介入放射学杂志,2012,(03):206.
,,et al.Ｔｈｅ ｆａｃｔｏｒｓ ｒｅｌａｔｅｄ ｔｏ ｔｈｅ ｆｏｒｍａｔｉｏｎ ｏｆ ａｒｔｅｒｉｏｐｏｒｔａｌ ｓｈｕｎｔｉｎｇ ｉｎ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ [J].journal interventional radiology,2012,(11):206.
[4]沈海洋,刘瑞宝,刘 岩,等. 肝右叶前、后段原发性肝癌TACE后VEGF及CD34的表达水平 ；[J].介入放射学杂志,2012,(06):469.
SHEN Hai- yang,LIU Rui- bao,LIU Yan,et al. The expression levels of vascular endothelial growth factor and CD34 in residual cancerous tissues of primary hepatocellular carcinoma located at anterior and posterior segments of right lobe liver after TACE[J].journal interventional radiology,2012,(11):469.
[5]李晓峰,钱国军,张 磊,等. 微波高功率条件下消融原发性肝癌的初步研究[J].介入放射学杂志,2011,(12):974.
LI Xiao-feng,QIAN Guo-jun,ZHANG Lei,et al.Microwave ablation with high output power for the treatment of hepatocellular carcinoma: a preliminary study[J].journal interventional radiology,2011,(11):974.
[6]彭辽河,胡晓燕,李 杰,等. 18F-FDG PET/CT显像在肝细胞癌TACE术后残留或复发病灶检出中的应用价值[J].介入放射学杂志,2012,(08):636.
PENG Liao- he,HU Xiao- yan,LI Jie,et al. Clinical application of 18F- FDG PET/CT imaging in detecting residual lesions or recurrence foci of hepatocellular carcinoma after TACE treatment[J].journal interventional radiology,2012,(11):636.
[7]陆小华,朱小庆,茅国新.肝细胞癌相关单核苷酸多态性的研究进展[J].介入放射学杂志,2013,(06):520.
LU Xiao? hua,ZHU Xiao? qing,MAO Guo? xin.. Hepatocellular carcinoma?蛳 related single nucleotide polymorphisms： recent advances in research[J].journal interventional radiology,2013,(11):520.
[8]姚雪松,闫 东,曾辉英,等.TACE联合索拉非尼治疗不能手术切除肝细胞癌介入治疗间隔时间的分析[J].介入放射学杂志,2014,(09):769.
YAO Xue song,YAN Dong,ZENG Hui ying,et al.TACE combined with sorafenib for inoperable hepatocellular carcinoma： analysis of treatment interval[J].journal interventional radiology,2014,(11):769.
[9]姚雪松,闫 东,曾辉英,等. TACE联合索拉非尼治疗不能手术切除肝细胞肝癌50例[J].介入放射学杂志,2013,(05):381.
YAO Xue? song,YAN Dong,ZENG Hui? ying,et al. Ttransarterial chemoembolization combined with sorafenib for inoperable hepatocellular carcinoma： a clinical analysis of 50 cases[J].journal interventional radiology,2013,(11):381.
[10]赵 松,陈学春,龙清云,等. 经肝动脉化疗栓塞联合射频消融治疗肝细胞癌疗效荟萃分析[J].介入放射学杂志,2013,(11):908.
ZHAO Song,CHEN Xue? chun,LONG Qing? yun,et al. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma： a systematic review and Meta analysis[J].journal interventional radiology,2013,(11):908.